NBTX (NBTX) Stock Price & Analysis
NBTX (NBTX) fell 4.06% to USD 36.64 as of September 9, 2026 at 22:50 UTC, according to Nexqual real-time market data.
NBTX last closed at USD 36.64; the session ranged USD 35.45–36.72 on volume of 104,826 shares. Market capitalization is —, with a 52-week range of USD 9.1–57.14 (NMS). Source: Nexqual, September 9, 2026 at 22:50 UTC.
Key Statistics (as of September 9, 2026 at 22:50 UTC)
| Price | USD 36.64 |
|---|---|
| Change | ▼ 4.06% (down) |
| Previous Close | USD 36.64 |
| Open | USD 36.64 |
| Day Range | USD 35.45 – 36.72 |
| 52-Week Range | USD 9.1 – 57.14 |
| Volume | 104,826 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (NBTX)
Nexqual's technical model rates NBTX "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 22:50 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.1 (neutral) |
| vs SMA50 | Below (USD 39.73) |
| MACD | -0.26 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PHVS | Pharvaris N.V. | USD 37.74 | ▲ 7.06% |
| IVA | Inventiva S.A. - American Depos | USD 4.45 | ▼ 6.9% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 14.18 | ▼ 5.28% |
| INBX | Inhibrx Biosciences, Inc. | USD 112.86 | ▼ 6.86% |
| OLMA | Olema Pharmaceuticals, Inc. | USD 10.36 | ▼ 3.63% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 22:50 UTC. This page is informational and not investment advice.